维普期刊资源整合服务平台（V6.5）

557篇 您的检索式：作者名="KASTRATI A"

选中清除导出查看参考文献查看引证文献引用追踪共28页首页上一页第1页下一页末页 /28 跳转

	题名	作者	年代	出处	被引量
1	A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel显示文摘	Kastrati A Mehilli J Schuhlen H	2004	N Engl J Med2004，350，：	1
2	Vessel size and long-term outcome after coronary stent placement显示文摘	Eleizi S Kastrati A Neumann F	1998	Circulation1998，98，18：	1
3	lntracoronary stentlng and angiographic results : strut thickness effect on restenosis outcome ( ISAR-STEREO-2 ) trial 显示文摘	Pache J Kastrati A MehiUi J	2003	J Am Coll Cardiol2003，41，8：	1
4	Clopido- grel therapy in patients undergoing coronary stenting:value of a high - loading - dose regimen 显示文摘	Pache J Kastrati A Mehilli J	2002	Catheter Cardiovasc Interv2002，55，：	1
5	Evaluation of prolonged antithrombotic pretreatment ( 'cooling-off' strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial 显示文摘	Neumann FJ Kastrati A Pogatsa-Murray G	2003	JAMA2003，290，：	1
6	The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders显示文摘	Bernlochner I Byrne RA Kastrati A	2011	Expert Rev Cardiovasc Ther2011，9，8：	1
7	Abeiximab and heparin versus bivalirudin for non-ST-elevation myocardial in-farction 显示文摘	Kastrati A Neumann F J Schulz S	2011	N Engl J Med2011，365，21：	1
8	Diabetes mellitus and the clinical and angiographic outcome after coronary stent piacement显示文摘	Elezi S Kastrati A Paehe J	1998	J AmColl Cardiol1998，32，7：	1
9	Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization显示文摘	Kandzari DE Berger PB Kastrati A	2004	J Am Coll Cardiol2004，44，：	1
10	Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction 显示文摘	Koch W Kastrati A Bottiger C	2001	Atherosclerosis2001，159，1：	1
11	Restenosis after coronary placement of various stent types显示文摘	Kastrati A Mehilli J Dirschinger J	2001	Am J Cardiol2001，87，1：	1
12	Circulating homoeysteine levels in patients with type 2 diabetes mellitus 显示文摘	Ndrepepa G Kastrati A Braun S	2008	Nutr Metab Cardiovasc Dis2008，68，2：	1
13	Abciximab in patients with acute coronary syndromes undergoing pereutaneous coronary intervention after elopidogrel pretreatment : the ISAR-REACT 2 randomized trial 显示文摘	Kastrati A Mehilli J Neumann FJ	2006	JAMA2006，295，13：	1
14	PIA polymorphism of platelet glycoprotein Ⅲa and risk of restenosis after coronary stent placement显示文摘	Kastrati A Schomig A Sefarth M	1999	Circulation1999，99，：	1
15	Restenosis after coronary placement of various stent types显示文摘	Kastrati A Mehilli J Dirschinger J	2001	Am J Cardiol2001，87，：	1
16	Analysis of 14 trials comparing sirolimuseluting stents with bare-metal stents 显示文摘	Kastrati A Mehilli J Pache J	2007	N Engl J Med2007，356，：	1
17	Analysis of 14 trials comparing sirolimus- eluting stents with bare-metal stents显示文摘	Kastrati A Mehilli J Pache J	2007	N Engl J Med2007，356，：	1
18	Drug-eluting stents in percutaneous coronary intervention:a benefit-risk assessment显示文摘	Byrne RA Sarafoff N Kastrati A	2009	Drug Saf2009，32，9：	1
19	HPA-1 and HPA-3 plymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction显示文摘	Bottiger C Kastrati A Koch W	2000	Thromb Haemost2000，83，4：	1
20	A randomized comparison antiplatelet and anticoagulant therapy after the placement of coronary-artery stents显示文摘	Schomig A Neumann FJ Kastrati A	1996	N Engl J Med1996，334，17：	1

返回顶部每页显示：

共28页首页上一页第1页下一页末页 /28 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示